Litigation Details for Purdue Pharma L.P. v. Depomed, Inc. (Fed. Cir. 2015)
✉ Email this page to a colleague
Purdue Pharma L.P. v. Depomed, Inc. (Fed. Cir. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-09-15 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,340,475; 6,635,280 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharma L.P. v. Depomed, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Purdue Pharma L.P. v. Depomed, Inc. (Fed. Cir. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-10-05 | 25 | Proceeding—Ex. 1001) ’475 patent U.S. Patent No. 6,340,475, titled “Extending The … of US Patent No 6,340,475 B2 Ex 1001 “the ’ 475 patent” Paper…2015 IPR2014 00378 Patent 6,340,475 B2 Patent Owner also argues…/2015 IPR2014 00378 Patent 6,340,475 B2 A patent claim is unpatentable… 00378 Patent 6,340,475 B2 these limitations For example as Patent Owner notes | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
